Published in Biol Psychiatry on September 01, 2003
Integrating Text Messages Into the Mothers and Babies Course | NCT03420755
Development, Feasibility and Acceptability of Fathers and Babies (FAB): A Pilot Study | NCT03427528
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD | NCT03932773
Electrophysiological Correlates of Cognition in Depression | NCT03998748
Assessing the Effectiveness of a CBT-based App in Reducing Suicidal Ideation | NCT04414774
Depression Screening in Black Churches | NCT04524767
Neurocognitive Effects of FMT in MDD Patients With and Without IBS | NCT05174273
Gemfibrozil for Nicotine Smoking Cessation (GEMNIC) | NCT02638597
Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding | NCT01451697
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry (2007) 8.11
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry (2013) 4.84
Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry (2011) 4.21
National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments. J Am Acad Child Adolesc Psychiatry (2009) 3.92
Epidemiology of major depressive disorder in elderly Nigerians in the Ibadan Study of Ageing: a community-based survey. Lancet (2007) 3.48
Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry (2006) 3.47
Harnessing context sensing to develop a mobile intervention for depression. J Med Internet Res (2011) 3.44
National comorbidity survey replication adolescent supplement (NCS-A): I. Background and measures. J Am Acad Child Adolesc Psychiatry (2009) 3.35
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.91
A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry (2010) 2.77
Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58
Depression care in the United States: too little for too few. Arch Gen Psychiatry (2010) 2.57
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet (2006) 2.55
Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med (2009) 2.42
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol (2009) 2.33
Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry (2010) 2.30
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry (2009) 2.15
Race and financial strain are independent correlates of sleep in midlife women: the SWAN sleep study. Sleep (2009) 2.13
Prognostic subgroups for citalopram response in the STAR*D trial. J Clin Psychiatry (2014) 2.10
Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry (2013) 1.96
Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry (2010) 1.92
A clinical risk stratification tool for predicting treatment resistance in major depressive disorder. Biol Psychiatry (2013) 1.90
The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry (2008) 1.86
Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety (2010) 1.85
Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry (2010) 1.85
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychol Med (2011) 1.83
The epidemiology of major depression and ethnicity in the United States. J Psychiatr Res (2010) 1.78
Insomnia and the performance of US workers: results from the America insomnia survey. Sleep (2011) 1.77
Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. Clin Pharmacol Ther (2010) 1.74
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatr Scand (2009) 1.67
The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord (2010) 1.61
Exergames for subsyndromal depression in older adults: a pilot study of a novel intervention. Am J Geriatr Psychiatry (2010) 1.59
Sleep hygiene behaviors among midlife women with insomnia or sleep-disordered breathing: the SWAN sleep study. J Womens Health (Larchmt) (2014) 1.58
Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. Am J Psychiatry (2012) 1.57
Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nat Neurosci (2013) 1.57
The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev (2009) 1.57
Treatment of maternal depression in a medication clinical trial and its effect on children. Am J Psychiatry (2015) 1.51
Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression. JAMA Psychiatry (2015) 1.48
Inference for optimal dynamic treatment regimes using an adaptive m-out-of-n bootstrap scheme. Biometrics (2013) 1.46
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med (2011) 1.45
Validation of depression screening scales in patients with CKD. Am J Kidney Dis (2009) 1.43
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry (2008) 1.42
The effects of positive patient testimonials on PTSD treatment choice. Behav Res Ther (2012) 1.41
Circadian polymorphisms associated with affective disorders. J Circadian Rhythms (2009) 1.39
Intrapersonal and interpersonal concomitants of facial blushing during everyday social encounters. PLoS One (2015) 1.39
Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. J Affect Disord (2014) 1.39
Finding a depression app: a review and content analysis of the depression app marketplace. JMIR Mhealth Uhealth (2015) 1.37
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry (2009) 1.35
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics. Pharmacogenet Genomics (2012) 1.34
Antidepressant use in black and white populations in the United States. Psychiatr Serv (2008) 1.33
SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet (2009) 1.32
The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry (2009) 1.29
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Arch Gen Psychiatry (2010) 1.29
Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology (2011) 1.28
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. J Gen Intern Med (2008) 1.28
Constructing evidence-based treatment strategies using methods from computer science. Drug Alcohol Depend (2007) 1.26
Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety (2014) 1.26
Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes. Stat Sci (2014) 1.25
Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder. Proc Biol Sci (2011) 1.25
Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh Sleep Quality Index. Sleep (2008) 1.24
The epidemiology of depression in metropolitan China. Psychol Med (2008) 1.22
Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav (2011) 1.22
Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. PLoS One (2008) 1.21
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr Psychiatry (2008) 1.20
Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial. Trials (2011) 1.19
Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend (2007) 1.19
Using a pharmacogenomic algorithm to guide the treatment of depression. Transl Psychiatry (2012) 1.19
Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep (2011) 1.19
Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry (2012) 1.17
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. Am J Psychiatry (2010) 1.16
The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry (2004) 1.15
A randomized controlled trial evaluating a manualized TeleCoaching protocol for improving adherence to a web-based intervention for the treatment of depression. PLoS One (2013) 1.14
The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder. BMC Psychiatry (2009) 1.14
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol (2011) 1.14
Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed (2012) 1.14
Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression. Psychol Med (2005) 1.13
Psychiatric epidemiology: it's not just about counting anymore. Arch Gen Psychiatry (2005) 1.12
Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res (2011) 1.12
Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. J Psychiatr Res (2006) 1.11
Emergency department use by released prisoners with HIV: an observational longitudinal study. PLoS One (2012) 1.11
Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms. J Clin Child Adolesc Psychol (2008) 1.11
Varenicline augmentation in depressed smokers: an 8-week, open-label study. J Clin Psychiatry (2009) 1.09
CYP2C19 variation and citalopram response. Pharmacogenet Genomics (2011) 1.09
Marital/cohabitation status and history in relation to sleep in midlife women. Sleep (2010) 1.09
Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar Disord (2012) 1.09
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. Eur J Health Econ (2010) 1.08
Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN Sleep Study. Sleep (2012) 1.08
The association of depression and anxiety with pain: a study from NESDA. PLoS One (2014) 1.07
Antidepressant effects of selective slow wave sleep deprivation in major depression: a high-density EEG investigation. J Psychiatr Res (2011) 1.07
Voice acoustic measures of depression severity and treatment response collected via interactive voice response (IVR) technology. J Neurolinguistics (2007) 1.07
Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery. Behav Res Ther (2011) 1.07
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study. Behav Modif (2014) 1.06
Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics (2009) 1.06
Measuring depression using item response theory: an examination of three measures of depressive symptomatology. Int J Methods Psychiatr Res (2012) 1.05
Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatr Serv (2009) 1.04
Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother Psychosom (2012) 1.04
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry (2002) 6.99
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA (2006) 6.26
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med (2006) 6.00
Medication augmentation after the failure of SSRIs for depression. N Engl J Med (2006) 5.16
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05
Exercise treatment for depression: efficacy and dose response. Am J Prev Med (2005) 4.99
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry (2006) 4.37
Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry (2002) 4.08
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry (2006) 3.90
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry (2008) 3.82
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2006) 3.66
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol (2008) 3.65
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry (2003) 3.59
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry (2005) 3.23
Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry (2005) 3.19
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry (2009) 3.17
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03
Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry (2003) 3.00
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol (2007) 2.99
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry (2006) 2.90
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry (2007) 2.84
Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry (2006) 2.84
The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry (2014) 2.82
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry (2013) 2.80
Improving clinical trials: American Society of Clinical Psychopharmacology recommendations. Arch Gen Psychiatry (2002) 2.70
Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry (2006) 2.69
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol (2007) 2.60
Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet (2006) 2.55
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. J Am Acad Child Adolesc Psychiatry (2011) 2.49
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43
Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry (2008) 2.42
Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. Am J Psychiatry (2002) 2.38
Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. J Clin Psychiatry (2011) 2.35
Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry (2011) 2.33
Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry (2005) 2.32
Psychiatric disorders in preschoolers: continuity from ages 3 to 6. Am J Psychiatry (2012) 2.26
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry (2007) 2.25
Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break. J Am Acad Child Adolesc Psychiatry (2011) 2.22
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry (2006) 2.21
Psychosocial functioning of young adults who have experienced and recovered from major depressive disorder during adolescence. J Abnorm Psychol (2003) 2.20
Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry (2010) 2.18
Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA (2010) 2.16
Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry (2004) 2.11
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry (2011) 2.10
The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep (2007) 2.08
Comparing cognitive behavior therapy, interpersonal psychotherapy, and psychodynamic psychotherapy. Am J Psychiatry (2004) 2.05
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2004) 2.04
Evidence-based recommendations for the prescription of exercise for major depressive disorder. J Psychiatr Pract (2013) 2.04
Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychiatry (2011) 2.00
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry (2005) 1.99
Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res (2013) 1.99
Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses? Int J Neuropsychopharmacol (2002) 1.99
Psychosocial intervention development for the prevention and treatment of depression: promoting innovation and increasing access. Biol Psychiatry (2002) 1.99
Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev (2005) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry (2009) 1.96
Substance use disorders among adolescents with bipolar spectrum disorders. Bipolar Disord (2008) 1.94
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry (2007) 1.93
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry (2008) 1.92
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90
The prevalence and co-morbidity of subthreshold psychiatric conditions. Psychol Med (2004) 1.89
Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract (2006) 1.89
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry (2007) 1.88
Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol (2007) 1.87
The pattern of sensory processing abnormalities in autism. Autism (2006) 1.83
Temperamental emotionality in preschoolers and parental mood disorders. J Abnorm Psychol (2005) 1.81
Gender differences in depression: findings from the STAR*D study. J Affect Disord (2005) 1.80
One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies. Biol Psychiatry (2004) 1.79
Effect of age at onset on the course of major depressive disorder. Am J Psychiatry (2007) 1.78
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.78
Is academic psychiatry for sale? Br J Psychiatry (2003) 1.78
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv (2009) 1.77